Revenue positive as of Jan 1, 2018.
612% user growth YOY (2016 - 2017).
17 implemented clients including Georgia Tech University.
$9.8 million in revenue since inception.
Over 70 Fortune 1000 customers.
Raised $1.3M from 975 investors on Wefunder.
Profitable – 11% monthly growth rate since Q2 2016.
290% yearly growth in paying subscribers.
500,000+ registered athletes in 150+ countries.
Our tech helps patients double their weight loss with fewer side effects than conventional interventions (i.e. diet, meds, devices, surgery.)
Founded by 2 obesity doctors using exclusive tech from Mayo Clinic (patents pending).
The blood test has been clinically validated in 2 randomized controlled Mayo Clinic trials to predict obesity drug response at 90% accuracy.
Projected (although not guaranteed) per Venue: $2.2 mm ticket sales, $1.2 mm COGS, $1 mm gross margin
Projected (although not guaranteed) 3 venues in 2019; 50+ venues in 5 years
5,000+ travelers so far at first location | Pacific Science Center, Seattle
$420K hard committed for this round
$310K pre-seed raised in 2017
1000+ users, 2 paying customers, & +30,000 person waitlist
5,000 Trustwire users since our launch in June 2018.
CEO & Founder Hugh Hall has been working in cybersecurity since 2002.
Reached over 1,000 users before public launch.
Online beta marketplace organically grew to over 90 cities in 19 states in 4 months.
Winners of the 2017 Silicon Valley Business Plan competition.
Average order size is $15.88.
Our technology outperformed standard charity checkout by tripling the donation rate from 8% to 25% in beta testing across 5 stores.
Team has two successful startup exits and a CEO with fundraising expertise.
Partnerships with major FinTech players such as Verifone, Ingenico, First Data, and Worldpay.
Privacy: We won’t share your data, or post to your wall, without your permission.
Already have an account? Login
Don't have an account? Signup